Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(R)-Glycerol 1-(p-toluenesulfonate) is a chiral synthon derived from glycerol, with a p-toluenesulfonate group attached to the primary hydroxyl group. It is a versatile compound used in various chemical reactions and synthesis processes due to its unique structural properties.

41274-09-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 41274-09-3 Structure
  • Basic information

    1. Product Name: (R)-Glycerol 1-(p-toluenesulfonate)
    2. Synonyms: (R)-GLYCEROL 1-(P-TOLUENESULFONATE);SN-GLYCEROL 1-(P-TOLUENESULFONATE);SN-GLYCERYL 1-(P-TOLUENESULFONATE);(R)-1-TOSYL-GLYCEROL;(R)-1-TOSYLOXY-2,3-PROPANEDIOL;(R)-2,3-DIHYDROXYPROPYL P-TOLUENESULFONATE;(R)-3-TOSYLOXY-1,2-PROPANEDIOL;(R)-1-Toxyloxy-2,3-propanediol
    3. CAS NO:41274-09-3
    4. Molecular Formula: C10H14O5S
    5. Molecular Weight: 246.28
    6. EINECS: N/A
    7. Product Categories: chiral;Chiral Reagents;Aromatics;Sulfur & Selenium Compounds
    8. Mol File: 41274-09-3.mol
  • Chemical Properties

    1. Melting Point: 54-59°C
    2. Boiling Point: 463 °C at 760 mmHg
    3. Flash Point: 233.8 °C
    4. Appearance: /
    5. Density: 1.351 g/cm3
    6. Vapor Pressure: 2.27E-09mmHg at 25°C
    7. Refractive Index: 1.559
    8. Storage Temp.: −20°C
    9. Solubility: Dichloromethane; Chloroform; Methanol; DMF;
    10. CAS DataBase Reference: (R)-Glycerol 1-(p-toluenesulfonate)(CAS DataBase Reference)
    11. NIST Chemistry Reference: (R)-Glycerol 1-(p-toluenesulfonate)(41274-09-3)
    12. EPA Substance Registry System: (R)-Glycerol 1-(p-toluenesulfonate)(41274-09-3)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: 36/37/38
    3. Safety Statements: 26-36
    4. WGK Germany: 3
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 41274-09-3(Hazardous Substances Data)

41274-09-3 Usage

Uses

Used in Pharmaceutical Industry:
(R)-Glycerol 1-(p-toluenesulfonate) is used as a chiral synthon for general asymmetric synthesis, which is crucial in the development of new pharmaceutical compounds with improved selectivity and potency. Its ability to serve as an intermediate in the synthesis of chiral aryloxypropanolamines makes it particularly valuable, as these compounds constitute the majority of known potent beta-adrenergic blockers. These blockers are essential in the treatment of various cardiovascular conditions, such as hypertension and心绞痛 (angina pectoris).

Check Digit Verification of cas no

The CAS Registry Mumber 41274-09-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,1,2,7 and 4 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 41274-09:
(7*4)+(6*1)+(5*2)+(4*7)+(3*4)+(2*0)+(1*9)=93
93 % 10 = 3
So 41274-09-3 is a valid CAS Registry Number.
InChI:InChI=1/C10H14O5S/c1-8-2-4-10(5-3-8)16(13,14)15-7-9(12)6-11/h2-5,9,11-12H,6-7H2,1H3/t9-/m1/s1

41274-09-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (G2410)  (R)-Glycerol1-(p-toluenesulfonate)  95% (TLC)

  • 41274-09-3

  • G2410-1G

  • 3,714.75CNY

  • Detail

41274-09-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name (R)-1-Tosyloxy-2,3-propanediol

1.2 Other means of identification

Product number -
Other names [(2R)-2,3-dihydroxypropyl] 4-methylbenzenesulfonate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:41274-09-3 SDS

41274-09-3Synthetic route

(R)-2,2-dimethyl-1,3-dioxolane-4-ylmethyl p-toluenesulfonate
23788-74-1

(R)-2,2-dimethyl-1,3-dioxolane-4-ylmethyl p-toluenesulfonate

(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

Conditions
ConditionsYield
With hydrogenchloride In acetone Heating;98%
With hydrogenchloride In methanol at 20℃; for 0.5h;98%
With Dowex 50X8 H(+) form In methanol at 60℃; for 7h;96%
(R)-(-)-3-tosyloxy-2-benzyloxy-1-propanol
119870-20-1

(R)-(-)-3-tosyloxy-2-benzyloxy-1-propanol

(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal In ethanol98%
((R)-2,2-cyclohexylidine-1,3-dioxolan-4-yl)methyl 4-methylbenzenesulphonate
1638138-12-1

((R)-2,2-cyclohexylidine-1,3-dioxolan-4-yl)methyl 4-methylbenzenesulphonate

(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

Conditions
ConditionsYield
With toluene-4-sulfonic acid In methanol at 20℃; for 24h;85%
(R)-(+)-3-tosyloxypropane-1,2-diol dipropionate
141656-30-6

(R)-(+)-3-tosyloxypropane-1,2-diol dipropionate

A

(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

B

(S)-1-tosyloxy-2,3-propanediol
50765-70-3

(S)-1-tosyloxy-2,3-propanediol

Conditions
ConditionsYield
With toluene-4-sulfonic acid In methanol at 60℃; for 3h; Yield given. Yields of byproduct given. Title compound not separated from byproducts;
allyl tosylate
4873-09-0

allyl tosylate

A

(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

B

(S)-1-tosyloxy-2,3-propanediol
50765-70-3

(S)-1-tosyloxy-2,3-propanediol

Conditions
ConditionsYield
With potassium dioxotetrahydroxoosmate(VI); potassium carbonate; potassium hexacyanoferrate(III); 1,4-bis(dihydroquinidinyl)anthraquinone In water; tert-butyl alcohol at 0℃; Yield given. Yields of byproduct given. Title compound not separated from byproducts;
(R)-3--1.2-isopropylidenedioxy-propane

(R)-3--1.2-isopropylidenedioxy-propane

(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

Conditions
ConditionsYield
With hydrogenchloride
p-toluenesulfonyl chloride
98-59-9

p-toluenesulfonyl chloride

(+-)-erythro-4-<4-nitro-benzoylamino>-pentan-2-ol

(+-)-erythro-4-<4-nitro-benzoylamino>-pentan-2-ol

(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 68 percent / pyridine / 16 h / 0 - 28 °C
2: 95 percent / 1N HCl / acetone / 0.5 h / Heating
View Scheme
p-toluenesulfonyl chloride
98-59-9

p-toluenesulfonyl chloride

2.4-dioxy-6-methoxy-benzophenone

2.4-dioxy-6-methoxy-benzophenone

(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: pyridine / 5 h / 20 °C
2: 3.166 g / TFA / H2O / 0.25 h / 20 °C
View Scheme
p-toluenesulfonyl chloride
98-59-9

p-toluenesulfonyl chloride

1-propyloxy-ethanol-(2)

1-propyloxy-ethanol-(2)

(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: Et3N / CH2Cl2 / Ambient temperature
2: 1 M HCl / acetone / 90 - 95 °C
View Scheme
p-toluenesulfonyl chloride
98-59-9

p-toluenesulfonyl chloride

l(+)-alanine

l(+)-alanine

(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 91 percent / pyridine
2: 98 percent / HCl / acetone / Heating
View Scheme
(R)-1-O-Acetyl-2-O-benzyl-3-tosylglycerol
128223-59-6

(R)-1-O-Acetyl-2-O-benzyl-3-tosylglycerol

(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 96 percent / 25percent NH4OH / methanol / 15 h / Ambient temperature
2: 98 percent / H2 / 5percent Pd/C / ethanol
View Scheme
p-toluenesulfonyl chloride
98-59-9

p-toluenesulfonyl chloride

(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 98 percent / pyridine / 15 h / Ambient temperature
2: 96 percent / 25percent NH4OH / methanol / 15 h / Ambient temperature
3: 98 percent / H2 / 5percent Pd/C / ethanol
View Scheme
Multi-step reaction with 2 steps
1: 2) NaOH / 1) Py., 2) EtOH, 0 deg C
2: 98 percent / H2 / 5percent Pd/C / ethanol
View Scheme
Multi-step reaction with 2 steps
1: pyridine / acetone / 0 °C
2: hydrogenchloride / methanol / 6 h / Reflux
View Scheme
(S) glycerol-1, 2-acetonide

(S) glycerol-1, 2-acetonide

2,2-dimethylvaleroyl chloride
15721-22-9

2,2-dimethylvaleroyl chloride

p-toluenesulfonyl chloride
98-59-9

p-toluenesulfonyl chloride

(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

Conditions
ConditionsYield
In pyridine; dichloromethane; acetone
(S) glycerol-1,2-acetonide

(S) glycerol-1,2-acetonide

p-toluenesulfonyl chloride
98-59-9

p-toluenesulfonyl chloride

(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

Conditions
ConditionsYield
With hydrogenchloride In pyridine; dichloromethane; acetone
(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

(R)-4-tosyloxymethyl-1,3,2-dioxathiolan-2-oxide

(R)-4-tosyloxymethyl-1,3,2-dioxathiolan-2-oxide

Conditions
ConditionsYield
With thionyl chloride; triethylamine In dichloromethane at 0℃; for 0.166667h;93%
α-naphthol
90-15-3

α-naphthol

(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

(R)-3-(1-naphthyloxy)-1,2-propanediol
61248-78-0

(R)-3-(1-naphthyloxy)-1,2-propanediol

Conditions
ConditionsYield
With sodium hydroxide In 1,4-dioxane; water at 80℃; for 16h;91%
pivaloyl imidazole
4195-19-1

pivaloyl imidazole

(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

(2R)-3-p-toluenesulphonyloxy-1-trimethylacetoxy-2-propanol
141110-71-6

(2R)-3-p-toluenesulphonyloxy-1-trimethylacetoxy-2-propanol

Conditions
ConditionsYield
With triethylamine In dichloromethane for 168h; Ambient temperature;88%
With triethylamine In methanol; dichloromethane; chloroform48.3 g (146 mmol, 88%)
With triethylamine In methanol; dichloromethane; chloroform48.3 g (146 mmol, 88%)
1,3,5-Trioxan
110-88-3

1,3,5-Trioxan

(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

1-O-tosyl-2,3-O-methylidene-D-glycerol
67800-64-0

1-O-tosyl-2,3-O-methylidene-D-glycerol

Conditions
ConditionsYield
With hydrogen cation In benzene Heating;87%
(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

trityl chloride
76-83-5

trityl chloride

(R)-1-tosyloxy-3-(triphenylmethyloxy)-2-propanol
41274-10-6

(R)-1-tosyloxy-3-(triphenylmethyloxy)-2-propanol

Conditions
ConditionsYield
With pyridine at 0℃; for 24h;85%
(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

Trimethylacetic acid
75-98-9

Trimethylacetic acid

(2R)-3-p-toluenesulphonyloxy-1-trimethylacetoxy-2-propanol
141110-71-6

(2R)-3-p-toluenesulphonyloxy-1-trimethylacetoxy-2-propanol

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃;78%
(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

1-hexadecylcarboxylic acid
57-10-3

1-hexadecylcarboxylic acid

1-palmitoyl-3-(p-toluenesulfonyl)-sn-glycerol
57984-42-6

1-palmitoyl-3-(p-toluenesulfonyl)-sn-glycerol

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 4h;72%
(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

(S)-1,2-Propanediol
4254-15-3

(S)-1,2-Propanediol

Conditions
ConditionsYield
With lithium aluminium tetrahydride In tetrahydrofuran at 0 - 20℃; for 4h;72%
(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

4-<1-(4-methylphenyl)sulfonyl-3-pyrrolyl>-4-oxobutanal
144024-32-8

4-<1-(4-methylphenyl)sulfonyl-3-pyrrolyl>-4-oxobutanal

A

(R)-(+)-2-<1-(4-methylphenyl)sulfonyl-4-indolyloxy>-3-<(4-methylphenyl)sulfonyloxy>-1-propanol
144024-35-1

(R)-(+)-2-<1-(4-methylphenyl)sulfonyl-4-indolyloxy>-3-<(4-methylphenyl)sulfonyloxy>-1-propanol

B

(R)-(-)-3-<1-(4-methylphenyl)sulfonyl-4-indolyloxy>-1-<(4-methylphenyl)sulfonyloxy>-2-propanol
144024-34-0

(R)-(-)-3-<1-(4-methylphenyl)sulfonyl-4-indolyloxy>-1-<(4-methylphenyl)sulfonyloxy>-2-propanol

Conditions
ConditionsYield
With sulfuric acid In dichloromethane for 3h; Heating;A 5.5%
B 71%
(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

(-)-(2S)-3-azidopropane-1,2-diol
85820-84-4

(-)-(2S)-3-azidopropane-1,2-diol

Conditions
ConditionsYield
With sodium azide In N,N-dimethyl-formamide for 24h; Reflux;70%
(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

4,4-dimethoxy-1-<1-(4-methylphenyl)sulfonyl-3-pyrrolyl>-1-butanone
144024-31-7

4,4-dimethoxy-1-<1-(4-methylphenyl)sulfonyl-3-pyrrolyl>-1-butanone

A

(R)-(+)-2-<1-(4-methylphenyl)sulfonyl-4-indolyloxy>-3-<(4-methylphenyl)sulfonyloxy>-1-propanol
144024-35-1

(R)-(+)-2-<1-(4-methylphenyl)sulfonyl-4-indolyloxy>-3-<(4-methylphenyl)sulfonyloxy>-1-propanol

B

(R)-(-)-3-<1-(4-methylphenyl)sulfonyl-4-indolyloxy>-1-<(4-methylphenyl)sulfonyloxy>-2-propanol
144024-34-0

(R)-(-)-3-<1-(4-methylphenyl)sulfonyl-4-indolyloxy>-1-<(4-methylphenyl)sulfonyloxy>-2-propanol

Conditions
ConditionsYield
With toluene-4-sulfonic acid In toluene for 3h; Heating;A 9%
B 68%
With toluene-4-sulfonic acid In toluene for 4h; Heating;A 11%
B 67%
(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

(R)-3-iodo-1,2-propanediol
40425-15-8

(R)-3-iodo-1,2-propanediol

Conditions
ConditionsYield
With sodium iodide In acetone at 90℃; for 9h;65%
12-(2'-naphthylacetyl)aminododecanoic acid p-nitrophenyl ester
932378-51-3

12-(2'-naphthylacetyl)aminododecanoic acid p-nitrophenyl ester

(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

1-(12'-N-[2''-naphthylacetyl]aminolauroyl)-3-(p-toluenesulfonyl)-sn-glycerol
932378-50-2

1-(12'-N-[2''-naphthylacetyl]aminolauroyl)-3-(p-toluenesulfonyl)-sn-glycerol

Conditions
ConditionsYield
With dmap In dichloromethane at 20℃; for 96h;58%
(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

1-(2,4-dichlorophenyl)ethan-1-one
2234-16-4

1-(2,4-dichlorophenyl)ethan-1-one

A

((2S,4R)-2-(2,4-dichlorophenyl)-2-methyl-1,3-dioxolan-4-yl)methyl 4-methylbenzenesulfonate

((2S,4R)-2-(2,4-dichlorophenyl)-2-methyl-1,3-dioxolan-4-yl)methyl 4-methylbenzenesulfonate

B

((2R,4R)-2-(2,4-dichlorophenyl)-2-methyl-1,3-dioxolan-4-yl)methyl 4-methylbenzenesulfonate

((2R,4R)-2-(2,4-dichlorophenyl)-2-methyl-1,3-dioxolan-4-yl)methyl 4-methylbenzenesulfonate

Conditions
ConditionsYield
With toluene-4-sulfonic acid In toluene for 48h; Reflux; Dean-Stark; Inert atmosphere;A 55%
B 30%
3,4-dihydro-2H-pyran
110-87-2

3,4-dihydro-2H-pyran

(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

1-hexadecylcarboxylic acid
57-10-3

1-hexadecylcarboxylic acid

1-palmitoyl-2-(tetrahydropyran-2-yl)-sn-glycerol
605680-00-0

1-palmitoyl-2-(tetrahydropyran-2-yl)-sn-glycerol

Conditions
ConditionsYield
Stage #1: (R)-3-tosyloxy-1,2-propanediol; 1-hexadecylcarboxylic acid With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃;
Stage #2: 3,4-dihydro-2H-pyran With toluene-4-sulfonic acid In dichloromethane at 20℃; Further stages;
52%
3,4-dihydro-2H-pyran
110-87-2

3,4-dihydro-2H-pyran

(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

stearic acid
57-11-4

stearic acid

C26H50O5

C26H50O5

Conditions
ConditionsYield
Stage #1: (R)-3-tosyloxy-1,2-propanediol; stearic acid With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃;
Stage #2: 3,4-dihydro-2H-pyran With toluene-4-sulfonic acid In dichloromethane at 20℃; Further stages;
49%
4-(4-chlorophenyl) piperazine
38212-33-8

4-(4-chlorophenyl) piperazine

(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

(R)-3-[4-(4-Chloro-phenyl)-piperazin-1-yl]-propane-1,2-diol

(R)-3-[4-(4-Chloro-phenyl)-piperazin-1-yl]-propane-1,2-diol

Conditions
ConditionsYield
In toluene for 18h; Heating;48%
4-phenyl-1-piperazine
92-54-6

4-phenyl-1-piperazine

(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

dextrodropropizine

dextrodropropizine

Conditions
ConditionsYield
In toluene for 18h; Heating;44%
1-(4-methoxyphenyl)piperazine
38212-30-5

1-(4-methoxyphenyl)piperazine

(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

(R)-3-[4-(4-Methoxy-phenyl)-piperazin-1-yl]-propane-1,2-diol

(R)-3-[4-(4-Methoxy-phenyl)-piperazin-1-yl]-propane-1,2-diol

Conditions
ConditionsYield
In toluene for 18h; Heating;40%
(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

100

100

(R)-3-[4-(2-Chloro-phenyl)-piperazin-1-yl]-propane-1,2-diol

(R)-3-[4-(2-Chloro-phenyl)-piperazin-1-yl]-propane-1,2-diol

Conditions
ConditionsYield
In toluene for 18h;38%
(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

1-(4-Fluorophenyl)piperazine
2252-63-3

1-(4-Fluorophenyl)piperazine

(R)-3-[4-(4-Fluoro-phenyl)-piperazin-1-yl]-propane-1,2-diol

(R)-3-[4-(4-Fluoro-phenyl)-piperazin-1-yl]-propane-1,2-diol

Conditions
ConditionsYield
In toluene for 18h; Heating;35%
(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

N-(m-chlorophenyl)piperazine
6640-24-0

N-(m-chlorophenyl)piperazine

(R)-3-[4-(3-Chloro-phenyl)-piperazin-1-yl]-propane-1,2-diol

(R)-3-[4-(3-Chloro-phenyl)-piperazin-1-yl]-propane-1,2-diol

Conditions
ConditionsYield
In toluene for 18h; Heating;30%
1-(2-Methoxyphenyl)piperazine
35386-24-4

1-(2-Methoxyphenyl)piperazine

(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

(R)-3-[4-(2-Methoxy-phenyl)-piperazin-1-yl]-propane-1,2-diol

(R)-3-[4-(2-Methoxy-phenyl)-piperazin-1-yl]-propane-1,2-diol

Conditions
ConditionsYield
In toluene for 18h; Heating;29%
(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

phenyl isocyanate
103-71-9

phenyl isocyanate

(R)-(3-phenyl-2-oxo-5-oxazolidinyl)methyl azide
96800-34-9

(R)-(3-phenyl-2-oxo-5-oxazolidinyl)methyl azide

Conditions
ConditionsYield
Multistep reaction.;23%
(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

phenyl isocyanate
103-71-9

phenyl isocyanate

(5R)-5-chloromethyl-3-phenyl-oxazolidin-2-one

(5R)-5-chloromethyl-3-phenyl-oxazolidin-2-one

Conditions
ConditionsYield
Multistep reaction.;22%
(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

phenyl isocyanate
103-71-9

phenyl isocyanate

A

(5R)-5-chloromethyl-3-phenyl-oxazolidin-2-one

(5R)-5-chloromethyl-3-phenyl-oxazolidin-2-one

B

5-(chloromethyl)-3-phenyloxazolidin-2-one

5-(chloromethyl)-3-phenyloxazolidin-2-one

Conditions
ConditionsYield
Multistep reaction;A n/a
B 21%
Multistep reaction;
(R)-3-tosyloxy-1,2-propanediol
41274-09-3

(R)-3-tosyloxy-1,2-propanediol

phenyl isocyanate
103-71-9

phenyl isocyanate

A

(5R)-5-chloromethyl-3-phenyl-oxazolidin-2-one

(5R)-5-chloromethyl-3-phenyl-oxazolidin-2-one

B

(S)-5-Azidomethyl-3-phenyl-oxazolidin-2-one
339301-73-4

(S)-5-Azidomethyl-3-phenyl-oxazolidin-2-one

Conditions
ConditionsYield
Multistep reaction;A n/a
B 15%

41274-09-3Relevant articles and documents

Enantiodivergent syntheses of (+)- and (?)-1-(2,6-dimethylphenoxy)propan-2-ol: A way to access (+)- and (?)-mexiletine from D-(+)-mannitol

Manna, Avrajit,Chatterjee, Sandip,Chakraborty, Ipsita,Bhaumik, Tanurima

, (2020/01/08)

Chiron approach was used to acquire optically pure (R)- and (S)-1-(2,6-dimethylphenoxy)propan-2-ol, immediate precursors of (S)- and (R)-mexiletines, respectively. Two different routes were followed from a D-mannitol-derived optically pure common precursor to get the enantiomeric alcohols separately. Comparison of their specific rotation values with the corresponding literature values as well as exact mirror-image relationship between their CD curves proved their high enantiopurity. These alcohols were then transformed to the corresponding amine-drugs in an efficient one-step process instead of two steps described in the literature.

SMALL MOLECULE INHIBITORS OF FIBROSIS

-

Paragraph 00472; 00478, (2016/06/28)

Described herein are compounds and compositions for the treatment of a fibrotic disease.

Repurposing the Clinically Efficacious Antifungal Agent Itraconazole as an Anticancer Chemotherapeutic

Pace, Jennifer R.,Deberardinis, Albert M.,Sail, Vibhavari,Tacheva-Grigorova, Silvia K.,Chan, Kelly A.,Tran, Raymond,Raccuia, Daniel S.,Wechsler-Reya, Robert J.,Hadden, M. Kyle

supporting information, p. 3635 - 3649 (2016/05/24)

Itraconazole (ITZ) is an FDA-approved member of the triazole class of antifungal agents. Two recent drug repurposing screens identified ITZ as a promising anticancer chemotherapeutic that inhibits both the angiogenesis and hedgehog (Hh) signaling pathways. We have synthesized and evaluated first- and second-generation ITZ analogues for their anti-Hh and antiangiogenic activities to probe more fully the structural requirements for these anticancer properties. Our overall results suggest that the triazole functionality is required for ITZ-mediated inhibition of angiogenesis but that it is not essential for inhibition of Hh signaling. The synthesis and evaluation of stereochemically defined des-triazole ITZ analogues also provides key information as to the optimal configuration around the dioxolane ring of the ITZ scaffold. Finally, the results from our studies suggest that two distinct cellular mechanisms of action govern the anticancer properties of the ITZ scaffold.

A Clickable and Photocleavable Lipid Analogue for Cell Membrane Delivery and Release

Alam, Shahrina,Alves, Daiane S.,Whitehead, Stuart A.,Bayer, Andrew M.,McNitt, Christopher D.,Popik, Vladimir V.,Barrera, Francisco N.,Best, Michael D.

, p. 1021 - 1031 (2015/06/30)

For drug delivery purposes, the ability to conveniently attach a targeting moiety that will deliver drugs to cells and then enable controlled release of the active molecule after localization is desirable. Toward this end, we designed and synthesized clickable and photocleavable lipid analogue 1 to maximize the efficiency of bioconjugation and triggered release. This compound contains a dibenzocyclooctyne group for bioorthogonal derivatization linked via a photocleavable 2-nitrobenzyl moiety at the headgroup of a synthetic lipid backbone for targeting to cell membranes. To assess delivery and release using this system, we report fluorescence-based assays for liposomal modification and photocleavage in solution as well as through surface immobilization to demonstrate successful liposome functionalization and photoinduced release. In addition, fluorophore delivery to and release from live cells was confirmed and characterized using fluorescence microscopy and flow cytometry analysis in which 1 was delivered to cells, derivatized, and photocleaved. Finally, drug delivery studies were performed using an azide-tagged analogue of camptothecin, a potent anticancer drug that is challenging to deliver due to poor solubility. In this case, the ester attachment of the azide tag acted as a caging group for release by intracellular esterases rather than through photocleavage. This resulted in a dose-dependent response in the presence of liposomes containing delivery agent 1, confirming the ability of this compound to stimulate delivery to the cytoplasm of cells.

Asymmetric synthesis and effect of absolute stereochemistry of YCZ-2013, a brassinosteroid biosynthesis inhibitor

Oh, Keimei,Yamada, Kazuhiro,Yoshizawa, Yuko

, p. 6915 - 6919 (2014/01/06)

The four stereoisomers of 2RS,4RS-1-[[2-(2,4-dichlorophenyl)-4-(2-(2- propenyloxy)phenoxymethyl)-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole (YCZ-2013), a novel brassinosteroid biosynthesis inhibitor, were prepared. The diastereomers of 2RS,4R-5 and 2RS,4S-5 were prepared by using the corresponding optically pure R and S toluene-4-sulfonic acid 2,3-dihydroxypropyl ester (R-4,S-4). The enatiomerically and diastereomerically pure acetonide (5) was obtained by a method involving diastereoselective crystallisation of the tosylate salt, followed by re-equilibration with the mother liquor and chromatography. The optical purity of four target compounds (YCZ-2013) was confirmed by chiral high-performance liquid chromatography (HPLC) and NMR. The effects of these stereoisomers on Arabidopsis stem elongation indicated that the cis isomers of 2S,4R-YCZ-2013 and 2R,4S-YCZ-2013 exhibited potent inhibitory activity with IC50 values of approximately 24 ± 3 and 24 ± 2 nM, respectively. The IC50 values of the trans isomers of 2S,4S-YCZ-2013 and 2R,4R-YCZ-2013 are approximately 1510 ± 50 and 3900 ± 332 nM, respectively. Co-application of brassinolide (10 nM), the most potent BR, and GA3 (1 μM) to Arabidopsis seedlings grown in the dark with 2R,4S-YCZ-2013 and 2S,4R-YCZ-2013 revealed that brassinolide recovered the induced dwarfism of Arabidopsis seedlings, whereas GA3 showed no effect.

A new synthesis of lysophosphatidylcholines and related derivatives. Use of p-toluenesulfonate for hydroxyl group protection

Rosseto, Renato,Bibak, Niloufar,DeOcampo, Rosemarie,Shah, Trishul,Gabrielian, Ara,Hajdu, Joseph

, p. 1691 - 1698 (2007/10/03)

A new stereoselective synthesis of lysophosphatidylcholines is reported. The synthesis is based upon (1) the use of 3-p-toluenesulfonyl-sn-glycerol to provide the stereocenter for construction of the optically active lysophospholipid molecule, (2) tetrahydropyranylation of the secondary alcohol function to achieve orthogonal protection of the sn-2- and sn-3-glycerol positions, and (3) elaboration of the phosphodiester headgroup using a 2-chloro-1,3,2-dioxaphospholane/trimethylamine sequence. In the course of developing the synthesis it has been discovered that methoxyacetate displacement of the sn-3-p-toluenesulfonate yields a reactive methoxyacetyl ester, which in turn can be selectively cleaved with methanol/tertbutylamine, while the ester group at the sn-1-position remains unaffected. The sequence has been shown to be suitable for preparation of spectroscopically labeled lysophosphatidylcholines. One of these compounds was readily converted to a double-labeled mixed-chain phosphatidylcholine applicable for real-time fluorescence resonance energy transfer (FRET) assay of lipolytic enzymes. In addition, the work led to new synthetic strategies based on chemoselective manipulation of the tosyl group in the presence of other base-labile groups such as FMOC derivatives that are often used for the protection of amino and hydroxyl groups in syntheses.

Nucleophilic reaction of glycidol tosylate and the corresponding cyclic sulfate with various nucleophiles: A comparative study

Lohray,Rajesh,Bhushan

, p. 586 - 592 (2007/10/03)

The nucleophilic reaction of glycidol tosylate and the corresponding cyclic sulfate tosylate have been carried out with a number of nucleophiles to study the possible attack of nucleophiles at C1, C2 or C3 positions. The regioselectivity and reactivity of both the substrates i.e. epoxide tosylate 1 and the corresponding cyclic sulfate 2 have been compared and established that under similar conditions cyclic sulfate counterpart shows better regioselectivity and better reactivity than the corresponding epoxide.

Polymer-aided stereodivergent synthesis (PASS): A new concept for the discrete preparation of optical antipodes

Ten Holte, Peter,Thijs, Lambertus,Zwanenburg, Binne

, p. 1093 - 1095 (2007/10/03)

A new concept to the discrete prepartion of optical antipodes is reported. The approach makes use of a cyclization/cleavage procedure that has been applied to polymer-supported quasi-meso compound 1, containing a polymeric leaving group and a regular leaving group. Two-directional cyclization leads to the formation and separation of quasi-enantiomers 2 and 3 simultaneously, with one being immobilized and on free in solution. Treatment of 2 and 3 with appropriate nucleophiles gives discrete enantiomers 4 and 5.

Assignment of the stereochemistry of spiroxamine by two-dimensional NMR spectroscopy and stereoselective chemical synthesis

Etzel,Gau,Kraemer,Stelzer,Weissmueller

, p. 64 - 68 (2007/10/03)

Spiroxamine is a new powdery mildew fungicide in cereals consisting of four biologically active isomers (two diastereomers, four enantiomers). The four isomers were separated by preparative high-performance liquid chromatography (HPLC) on a chiral stationary phase. At this stage it was not possible to assign their stereochemistry. Using stereoselective synthesis starting with the corresponding chirally pure glycerol derivates, the configuration at the asymmetric center, could be fixed. The resulting diastereomers were separated by preparative HPLC. Using COSY, HSQC and NOESY NMR spectroscopy it was possible to assign the configuration of the amino residue relative to the cyclohexyl ring. The 600 MHz 1H NMR spectra permitted a complete assignment of all proton signals. The stereochemical assignment is based on NOEs observed in the NOESY spectrum.

Eine neue Ligandenklasse fuer die asymmetrische Dihydroxylierung von Olefinen

Becker, Heinrich,Sharpless, K. Barry

, p. 447 - 449 (2007/10/03)

Keywords: Asymmetrische Dihydroxylierungen; Chirale Liganden; Chinchonaalkaloide; Katalyse; Osmiumverbindungen

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 41274-09-3